Rare diseases may impact a small portion of the population, yet their significance is profound. And while rare disease patient recruitment might seem similar to recruitment for more prevalent conditions, it's a puzzle of its own. Conditions affecting a fraction of the population present complex obstacles. From the intricate challenge of participant scarcity, where the rarity of these conditions presents a unique hurdle, to the multi-faceted complexities of engagement, the world of rare disease trials demands innovative strategies that reframe the way we approach research.
Our latest report details these challenges, and presents practical strategies addressing the scarcity of eligible candidates and the intricacies of participant engagement. In addition, we explore how cross-industry partnerships are changing the dynamics of clinical trials, particularly in rare disease research.
For all the details, download the report below!
